Drug Trial Radar · NCT00086255
Tiagabine for the Treatment of Cocaine Dependence - 1
Last checked: Nov 19, 2026Latest source record: Jan 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
140
Actual
Start
Oct 2002
Primary completion
Not stated
Study completion Jun 2004
Sponsor
- Lead sponsor
- National Institute on Drug Abuse (NIDA)NIH
- Sponsor type
- NIH
- Collaborators
- University of Cincinnati
- First posted
- Jun 30, 2004
Design
- Study type
- Interventional
- Phase
- Phase 2
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess tiagabine for the treatment of cocaine dependence.
Conditions
- Cocaine-Related Disorders
Interventions
TiagabineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Drug use
- Cocaine use
- Addiction severity
- Clinical improvement
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Boston University Medical Center
Boston, Massachusetts
Cincinnati VA Medical Center
Cincinnati, Ohio
Dayton VA Medical Center
Dayton, Ohio
University of Texas Hlth Sci Ctr Houston
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.